Abstract-Dynorphin is a potent opioid peptide.
Dynorphin is a heptadecapeptide which contains a leucine-enkephalin sequence as its amino terminal end (1, 2) . lmmunoreactive dynorphin has been shown to be distributed in the central nervous system, the pituitary gland and peripheral nervous system (3) (4) (5) . A synthetic dynorphin-(1-13) (Dyn) is potent as natural dynorphin- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) in bioassay (6), and it has been shown to produce analgesia and catalepsy (7), alteration in centrally stimulated gastric acid secretion (8) and spontaneous feeding (9). However, the physiological role of dynorphin is at present uncertain. In this study, we report that Dyn stimulates the isolated rat mast cells to extrude granules and release histamine by a exocytotic mechanism. A preliminary report of these data has been published (10). 
Results

Induction of histamine release by Dyn:
Synthetic Dyn induced histamine release from isolated mast cells in a dose-dependent manner over the concentration range 10-7-10-5 M (Fig. 1) . Phase contrast observations of mast cells responding to Dyn showed granule extrusion (Fig. 2) (Fig. 8a ). This inhibition was dependent upon the incubation time with cromoglycate before addition of Dyn (Fig. 8b) . The addition of cromoglycate 30 sec before Dyn inhibited markedly histamine release from mast cells, but such inhibition was abolished after a 2-min incubation with cromoglycate.
Naloxone (10-6-10-4 M) and leucineenkephalin (10-7-10-4 M) had little effect on the mast cells and on the Dyn-induced histamine release. Discussion We have shown here that Dyn induces histamine release from isolated rat peritoneal mast cells concomitantly with their degranulation. This histamine release is not accompanied by leakage of LDH. The response to Dyn is dependent on temperature and pH in the reaction medium. Calcium enhances the histamine release induced by Dyn. These data indicate that Dyn causes the release of histamine by an exocytotic mechanism.
The histamine release induced by Dyn was augmented by the extracellular calcium, but a significant release of histamine persisted in the absence of calcium. Addition of EDTA in the absence of calcium did not abolish the histamine release by Dyn. However, we could not observe the restoration of histamine release by calcium after prolonged treatment of the cells with EDTA, as previously observed by Douglas and Ueda (14). The stimulant effect of Dyn would therefore be that it acts by utilizing extracellular calcium or by mobilizing cellular calcium which mediates the releasing response.
Calcium-induced histamine release from the cells activated by Dyn in the Ca2+-free medium decayed with time and decreased on further exposure to Dyn. The time sequence of inactivation was similar to the process of desensitization to antigen described by Foreman and Garland (15). They suggested that mast cells limited the entry of calcium after stimulation by shutting-down Ca channels opened by the stimulus. Cromoglycate has been shown to inhibit exocytosis from mast cells stimulated with a variety of agents such as antigen (17), compound 48/80 (18, 19), dextran (20) and neurotensin (21). The histamine release induced by Dyn was also inhibited by cromoglycate in a dose-dependent fashion. This inhibitory action was effective by the treatment with this agent for very short periods of time. These conform to a familiar pattern observed with various other agents in mast cells (22) . Cromoglycate might have a stabilizing effect on the mast cell membrane involved in exocytosis. However, the mechanism of action of cromoglycate in the inhibitory effect is at present uncertain.
The actions of Dyn in bioassay systems such as guinea pig ileum and mouse was deferens are antagonized by naloxone (6), and it has been shown that Dyn acts as a mine release was not inhibited by both naloxone and leucine-enkephalin. The histamine release from the mast cells was also not induced by leucine-enkephalin alone. These findings indicate that histamine release by Dyn is not probably mediated by opioid receptors of the mast cells.
Certain basic biologically active peptides are known to acts as histamine releasers from mast cells (21, 24, 25). Dynorphin contains the leucine-enkephalin sequence at its Nterminus, followed by its C-terminus in which basic amino acids predominate. Dynorphin-(1-13) contains five basic amino acids in its peptide structure. Therefore, the releasing response to Dyn may reflect the stimulating effect of basic peptides observed by Johnson and Erdos (24).
